Concepts (120)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| High-Throughput Nucleotide Sequencing | 8 | 2021 | 316 | 0.610 |
Why?
|
| Mutation | 8 | 2025 | 2675 | 0.500 |
Why?
|
| Carcinoma, Squamous Cell | 3 | 2025 | 264 | 0.490 |
Why?
|
| Anus Neoplasms | 2 | 2025 | 25 | 0.390 |
Why?
|
| Biomarkers, Tumor | 5 | 2025 | 527 | 0.360 |
Why?
|
| Gene Deletion | 2 | 2018 | 312 | 0.320 |
Why?
|
| Urinary Bladder Neoplasms | 2 | 2021 | 109 | 0.290 |
Why?
|
| Adenocarcinoma | 2 | 2024 | 367 | 0.280 |
Why?
|
| Tumor Suppressor Protein p53 | 2 | 2021 | 314 | 0.260 |
Why?
|
| DNA Mutational Analysis | 7 | 2025 | 198 | 0.240 |
Why?
|
| Skin Neoplasms | 2 | 2024 | 411 | 0.230 |
Why?
|
| Deubiquitinating Enzyme CYLD | 1 | 2025 | 5 | 0.220 |
Why?
|
| Carcinoma, Adenoid Cystic | 1 | 2025 | 8 | 0.220 |
Why?
|
| Cyclic AMP Response Element-Binding Protein | 1 | 2005 | 45 | 0.220 |
Why?
|
| Muscular Atrophy, Spinal | 1 | 2005 | 25 | 0.210 |
Why?
|
| Nevus | 1 | 2024 | 23 | 0.200 |
Why?
|
| Sweat Gland Neoplasms | 1 | 2024 | 20 | 0.200 |
Why?
|
| Papillomavirus Infections | 2 | 2025 | 134 | 0.190 |
Why?
|
| Stomach Diseases | 1 | 2022 | 9 | 0.190 |
Why?
|
| Choristoma | 1 | 2022 | 23 | 0.180 |
Why?
|
| Nerve Tissue Proteins | 1 | 2005 | 428 | 0.180 |
Why?
|
| Rectal Diseases | 1 | 2022 | 29 | 0.180 |
Why?
|
| RNA-Binding Proteins | 1 | 2005 | 446 | 0.170 |
Why?
|
| Urinary Bladder | 1 | 2021 | 48 | 0.160 |
Why?
|
| Urine | 1 | 2021 | 47 | 0.160 |
Why?
|
| Carcinoma, Transitional Cell | 1 | 2021 | 46 | 0.160 |
Why?
|
| Proto-Oncogene Proteins B-raf | 3 | 2016 | 55 | 0.160 |
Why?
|
| Oncogenes | 2 | 2018 | 70 | 0.150 |
Why?
|
| Appendiceal Neoplasms | 1 | 2018 | 9 | 0.140 |
Why?
|
| Adenocarcinoma, Mucinous | 1 | 2018 | 31 | 0.140 |
Why?
|
| Receptors, Somatomedin | 1 | 2018 | 10 | 0.140 |
Why?
|
| Receptor, ErbB-4 | 1 | 2018 | 10 | 0.140 |
Why?
|
| Adenoma, Oxyphilic | 1 | 2018 | 11 | 0.140 |
Why?
|
| Retinoblastoma Binding Proteins | 1 | 2018 | 9 | 0.140 |
Why?
|
| Carcinoma, Lobular | 1 | 2018 | 28 | 0.130 |
Why?
|
| Polymerase Chain Reaction | 4 | 2016 | 514 | 0.130 |
Why?
|
| Insulin Receptor Substrate Proteins | 1 | 2018 | 61 | 0.130 |
Why?
|
| Middle Aged | 13 | 2025 | 18501 | 0.130 |
Why?
|
| ras Proteins | 2 | 2016 | 76 | 0.130 |
Why?
|
| Neoplasm Regression, Spontaneous | 1 | 2016 | 4 | 0.120 |
Why?
|
| Carcinoma, Merkel Cell | 1 | 2016 | 9 | 0.120 |
Why?
|
| Immunohistochemistry | 5 | 2016 | 899 | 0.120 |
Why?
|
| 5-Methylcytosine | 1 | 2016 | 24 | 0.120 |
Why?
|
| Carcinoma, Renal Cell | 1 | 2018 | 113 | 0.120 |
Why?
|
| Histiocytic Sarcoma | 1 | 2016 | 4 | 0.120 |
Why?
|
| Histiocytosis, Langerhans-Cell | 1 | 2016 | 16 | 0.120 |
Why?
|
| Aged | 11 | 2025 | 15147 | 0.120 |
Why?
|
| Sarcoma | 1 | 2016 | 36 | 0.120 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2018 | 229 | 0.120 |
Why?
|
| Kidney Neoplasms | 1 | 2018 | 173 | 0.120 |
Why?
|
| Adult | 11 | 2025 | 17579 | 0.110 |
Why?
|
| Head and Neck Neoplasms | 1 | 2016 | 166 | 0.110 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-3 | 1 | 2015 | 21 | 0.110 |
Why?
|
| Female | 14 | 2025 | 34425 | 0.110 |
Why?
|
| Hemangiosarcoma | 1 | 2015 | 25 | 0.110 |
Why?
|
| Biopsy | 1 | 2016 | 463 | 0.110 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 3 | 2024 | 65 | 0.110 |
Why?
|
| Male | 13 | 2025 | 31410 | 0.110 |
Why?
|
| MAP Kinase Signaling System | 1 | 2016 | 235 | 0.110 |
Why?
|
| Lung Diseases | 1 | 2016 | 183 | 0.110 |
Why?
|
| Proto-Oncogene Proteins c-myc | 1 | 2015 | 113 | 0.100 |
Why?
|
| Sebaceous Gland Neoplasms | 1 | 2014 | 10 | 0.100 |
Why?
|
| Leukemia, Myeloid, Acute | 1 | 2016 | 193 | 0.100 |
Why?
|
| DNA Mismatch Repair | 1 | 2014 | 35 | 0.100 |
Why?
|
| Central Nervous System Neoplasms | 1 | 2013 | 39 | 0.100 |
Why?
|
| Humans | 18 | 2025 | 65845 | 0.100 |
Why?
|
| Melanocytes | 1 | 2013 | 77 | 0.090 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2014 | 344 | 0.090 |
Why?
|
| Aged, 80 and over | 5 | 2025 | 5682 | 0.090 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2014 | 441 | 0.080 |
Why?
|
| Diagnosis, Differential | 3 | 2019 | 993 | 0.080 |
Why?
|
| Melanoma | 1 | 2013 | 335 | 0.080 |
Why?
|
| Breast Neoplasms | 2 | 2018 | 1235 | 0.080 |
Why?
|
| Nuclear Proteins | 1 | 2014 | 793 | 0.070 |
Why?
|
| Immunophenotyping | 2 | 2021 | 194 | 0.070 |
Why?
|
| Molecular Diagnostic Techniques | 1 | 2007 | 35 | 0.060 |
Why?
|
| Chromosome Aberrations | 1 | 2007 | 70 | 0.060 |
Why?
|
| Neoplasm Staging | 2 | 2018 | 554 | 0.060 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2007 | 297 | 0.060 |
Why?
|
| Genetic Carrier Screening | 1 | 2005 | 15 | 0.060 |
Why?
|
| SMN Complex Proteins | 1 | 2005 | 6 | 0.060 |
Why?
|
| Prognosis | 2 | 2021 | 1793 | 0.050 |
Why?
|
| Real-Time Polymerase Chain Reaction | 2 | 2016 | 211 | 0.050 |
Why?
|
| Exons | 1 | 2005 | 208 | 0.050 |
Why?
|
| Genetic Testing | 1 | 2005 | 144 | 0.050 |
Why?
|
| Gastric Mucosa | 1 | 2022 | 53 | 0.050 |
Why?
|
| Rectum | 1 | 2022 | 97 | 0.040 |
Why?
|
| Phenotype | 1 | 2025 | 1236 | 0.040 |
Why?
|
| Class I Phosphatidylinositol 3-Kinases | 1 | 2018 | 9 | 0.040 |
Why?
|
| Molecular Targeted Therapy | 1 | 2019 | 129 | 0.040 |
Why?
|
| Neoplasm Grading | 1 | 2018 | 102 | 0.040 |
Why?
|
| beta Catenin | 1 | 2018 | 100 | 0.030 |
Why?
|
| Receptor, IGF Type 1 | 1 | 2018 | 30 | 0.030 |
Why?
|
| Clinical Decision-Making | 1 | 2019 | 170 | 0.030 |
Why?
|
| Genes, Tumor Suppressor | 1 | 2018 | 78 | 0.030 |
Why?
|
| Neoplasm Invasiveness | 1 | 2018 | 289 | 0.030 |
Why?
|
| Mutation, Missense | 1 | 2018 | 190 | 0.030 |
Why?
|
| Lymph Nodes | 1 | 2018 | 237 | 0.030 |
Why?
|
| Jaw | 1 | 2016 | 4 | 0.030 |
Why?
|
| Merkel cell polyomavirus | 1 | 2016 | 5 | 0.030 |
Why?
|
| History, 17th Century | 1 | 2016 | 6 | 0.030 |
Why?
|
| Sentinel Lymph Node Biopsy | 1 | 2016 | 47 | 0.030 |
Why?
|
| Survival Rate | 1 | 2018 | 849 | 0.030 |
Why?
|
| MAP Kinase Kinase 1 | 1 | 2016 | 16 | 0.030 |
Why?
|
| Young Adult | 2 | 2016 | 4883 | 0.030 |
Why?
|
| DNA, Viral | 1 | 2016 | 232 | 0.030 |
Why?
|
| Neoplasms, Radiation-Induced | 1 | 2015 | 26 | 0.030 |
Why?
|
| MutL Protein Homolog 1 | 1 | 2014 | 27 | 0.030 |
Why?
|
| Vascular Diseases | 1 | 2015 | 83 | 0.030 |
Why?
|
| Breast | 1 | 2015 | 194 | 0.020 |
Why?
|
| Epigenesis, Genetic | 1 | 2016 | 408 | 0.020 |
Why?
|
| Smoking | 1 | 2016 | 864 | 0.020 |
Why?
|
| Time Factors | 1 | 2016 | 3779 | 0.020 |
Why?
|
| Gene Dosage | 1 | 2007 | 72 | 0.020 |
Why?
|
| Abnormalities, Multiple | 1 | 2007 | 54 | 0.020 |
Why?
|
| Retrospective Studies | 1 | 2019 | 6957 | 0.020 |
Why?
|
| Developmental Disabilities | 1 | 2007 | 119 | 0.010 |
Why?
|
| Adolescent | 1 | 2016 | 6368 | 0.010 |
Why?
|
| Intellectual Disability | 1 | 2007 | 177 | 0.010 |
Why?
|
| Child | 1 | 2007 | 4653 | 0.010 |
Why?
|